RICHESSE EXO19

RICHESSE™ EXO19 redefines the future of skincare with immune exosomes derived through advanced Dynamic Linker Cell (DLC) technology. Engineered for precision and performance, EXO19 delivers high-purity immune exosomes that deeply support skin repair, rejuvenation, and balance—making it a breakthrough in regenerative aesthetics.

Formulated with FDA-approved ingredients and produced using GMP-like novel precursor cells, EXO19 offers up to 100 times higher production capacity compared to conventional methods. Its high-purification refining process guarantees stringent quality control for consistently safe and effective results.

This ready-to-use, fast-absorbing liquid formula ensures optimal penetration and rapid visible improvement, promoting smoother, healthier, and more radiant skin. Beyond aesthetics, Richesse EXO19 is rooted in medical innovation—utilizing immune exosomes originally researched to enhance cancer treatments, boost antibody production, and improve vaccine effectiveness.

Whether used in clinical treatments or premium skin care routines, EXO19 is a smart, science-backed choice for high-performance skin regeneration. For more details, please request the product brochure from our sales representative.

Advanced immune exosomes from DLC technology | Rapid skin regeneration and repair | Enhances skin balance and rejuvenation | FDA-approved ingredients | Fast-absorbing ready-to-use liquid | Supports smoother, healthier, radiant skin | 100x production efficiency vs. competitors | High-purity refining with stringent quality control | Backed by research in immunotherapy and vaccine response